Developing a robust, automated, and streamlined clinical NGS workflow for hematological malignancies

Next-generation sequencing (NGS) has transformed the field of oncology. Early successes in identifying and targeting oncogenic drivers of solid tumors have set the foundation for genomics-guided precision medicine; but, for hematological malignancies, the path to precision medicine is a lot more complex.

In this application note, we discuss the importance of streamlined clinical NGS workflows within the hematologic-oncology space. To effectively characterize the clinical heterogeneity of myeloid malignancies, routine diagnostic labs must pair highly sensitive, multi-gene assays with indication-specific bioinformatic pipelines that provide up-to-date information on disease classification, prognostication, treatment selection, and monitoring.

Thank you for your message.

Download the application note to learn how to develop a robust, automated, and streamlined NGS analysis pipeline for the interpretation and reporting of genomic alterations associated with hematological malignancies.

Dummy field DO NOT USE Need to be hidden in CSS on LP
If Opp Type is INSTRUMENT // For SP creation / could be hidden field
If Opp Type is INSTRUMENT // For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
For SP creation / could be hidden field
Required only for USA & Canada


I hereby give QIAGEN the consent to contact me via email and phone (subject to the contact information provided above) with further contests, special offers and product information.

* Mandatory fields

Subject to your consent given above, by clicking on "submit," QIAGEN may use your personal information to communicate with you regarding this topic. QIAGEN may also use your personal information for internal business and marketing purposes that may include regular promotional offers, news, invitations via email or telephone. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by SalesForce.com, Inc. and Oracle Corp.) solely for the purposes of data hosting, phone calls and QIAGEN email distribution. You may unsubscribe at any time. Your data will be processed in compliance with applicable privacy laws including the EU General Data Protection Regulation. All information you provide in this site will be governed by our Privacy Policy.